MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development.
Together with our partners, we manage a portfolio of 65 projects, the largest portfolio of antimalarial R&D and access projects ever assembled. The portfolio includes nine new drugs in clinical development addressing unmet medical needs in malaria, including medicines for children, pregnant women and relapsing malaria, and drugs that could support the elimination/eradication agenda.
***Don't miss our 15th call for proposals — now open!***